Loading clinical trials...
Loading clinical trials...
Identification of New Biomarkers for Patients With Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) - do They Provide New Information Regarding Diagnosis, Treatment Efficacy, Side Effects, or Prognosis?
Conditions
Locations
1
Denmark
Herlev & Gentofte Hospital
Herlev, Copenhagen, Denmark
Start Date
January 1, 2015
Primary Completion Date
December 31, 2030
Completion Date
December 31, 2030
Last Updated
January 11, 2022
NCT05969860
NCT06503146
NCT06282575
NCT07486713
NCT05489211
NCT07151118
Lead Sponsor
Herlev and Gentofte Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions